© Reuters. J&J Earnings, Revenue Beat in Q3
Investing.com – J&J reported on Tuesday third quarter that beat analysts’ forecasts and revenue that topped expectations.
J&J announced earnings per share of $2.55 on revenue of $23.79. Analysts polled by Investing.com anticipated EPS of $2.52 on revenue of $23.46B.
J&J shares are down 2% from the beginning of the year, still down 10.77% from its 52 week high of $186.69 set on April 25.
J&J follows other major Healthcare sector earnings this month
J&J’s report follows an earnings beat by UnitedHealth on Friday, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
Exelixis had beat expectations on August 9 with second quarter EPS of $0.22 on revenue of $419.43M, compared to forecast for EPS of $0.203 on revenue of $391.03M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Be the first to comment